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Abstract
We have developed an approach for simultaneous detection of individual endogenous protein modifications and mRNA
molecules in single cells in situ. For this purpose we combined two methods previously developed in our lab: in situ
proximity ligation assay for the detection of individual protein interactions and -modifications and in situ detection of single
mRNA molecules using padlock probes. As proof-of-principle, we demonstrated the utility of the method for simultaneous
detection of phosphorylated PDGFRb and DUSP6/MKP-3 mRNA molecules in individual human fibroblasts upon PDGF-BB
stimulation. Further we applied drugs disrupting the PDGFRb signaling pathway at various sites to show that this combined
method can concurrently monitor the molecular effect of the drugs, i.e. inhibition of downstream signaling from the
targeted node in the signaling pathway. Due to its ability to detect different types of molecules in single cells in situ the
method presented here can contribute to a deeper understanding of cell-to-cell variations and can be applied to e.g.
pinpoint effector sites of drugs in a signaling pathway.
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Introduction
Studying molecules in their natural cellular context provides
valuable means to learn more about the complex function and
regulation of cells. Cellular activity can be determined at several
levels of complexity. Protein or mRNA expression can be used to
determine endpoint effects of an active signaling pathway, but in
order to investigate propagation of the signals assays for protein
interactions and post-translational modifications are needed. So
far most of the studies on protein-protein interactions and -
modifications as well as mRNA-expression levels have been
performed in a bulk population, rather than in individual cells, due
to restrictions in detection sensitivity and specificity of the methods
available. These methods yield average information about the
molecule of interest but will fail to detect intercellular variation [1].
Studies that are based on single cell data circumvent the risk that
rare events are hidden within the bulk population or that the
average for the whole population is not reflecting real variations
within it. This is of particular importance when studying cellular
signaling, since each cell in a population – even if they are clonal
expansions from one precursor – will answer slightly different to a
stimulus due to variations in e.g. cell cycle, accessibility to ligand
and transcription factors, accumulated mutations and the cocktail
of other signals this cell is receiving [2,3]. Visualization of multiple
nodes in a signaling pathway will enhance the ability to monitor
signal progression and provide a better tool to address heteroge-
neity in the response of a cell population to stimulation, enabling
studies on cellular communication.
To facilitate investigations of endogenous protein interactions
and post-translational modifications in situ we recently developed
the in situ proximity ligation assay (in situ PLA [4,5]). For detection
of DNA and individual mRNA molecules in situ we developed the
padlock probes that enable discrimination between single
nucleotide polymorphisms (SNP:s) [6,7]. Both methods allow the
detection of single molecules – either proteins or nucleic acid
molecules – in fixed cells and tissues. Briefly, in situ PLA as applied
here utilizes two antibodies from different species, one directed
against the protein of interest, the other against its posttransla-
tional modification. Upon binding to the same modified protein,
species-specific PLA probes directed against the primary antibod-
ies and carrying two different oligonucleotides are added (Figure 1).
Only if these bind in close proximity to the same target protein will
they guide the hybridization and ligation of two connector
oligonucleotides, generating a circular DNA molecule that is
amplified by a strictly circle-dependent rolling circle amplification
(RCA) using phi29 DNA polymerase. This reaction is primed from
one of the oligonucleotides attached to the PLA probes and thus
the single stranded RCA product (RCP) will stay attached to the
place where the PLA probe was bound. The RCP collapses into a
bundle of DNA, consisting of ,1000 repetitive elements,
complementary to the DNA circle. This bundle can then be
easily detected by hybridization with fluorescence labeled
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e20148detection oligonucleotides, concentrating ,1000 fluorophores in a
sub-mm sized bright spot, to be visualized by fluorescence
microscopy.
Padlock probes for detection of individual mRNA molecules [7]
also utilize RCA to visualize the detected molecules. The mRNA
molecules are first reverse transcribed into cDNA, using a specific
LNA-primer, to enable ligation of the padlock probes on cDNA
target molecules, which is a more efficient target than RNA. To
create a single-stranded cDNA target, the original mRNA is
digested by RNase H, except for the part that is tightly hybridized
to the LNA-modified nucleotides of the primer. This will keep the
synthesized cDNA anchored to the mRNA in the cell. A padlock
probe is then hybridized to the cDNA and upon perfect match the
target complementary 59 and 39 ends will become joined by
ligation, creating a circular DNA molecule (Figure 1). Since the
ligase is very sensitive to mismatches at the ligation junction,
padlock probes can be used for discrimination of SNP:s in situ
[6,7,8]. After circularization, the padlock probe is used as template
for an RCA primed from the cDNA, ensuring that the RCP stays
attached to the original target position in the cell. Visualization is
subsequently done as described for in situ PLA. As both methods
outlined here are able to investigate individual molecules of
different types we wanted to combine in situ PLA and padlock
probes for detection of individual protein modifications and
mRNA molecules to provide an assay to measure activity at
different positions in the signaling pathway, giving a more
coherent view on the status of individual cells.
The platelet-derived growth factor receptor beta (PDGFRb)i sa
receptor tyrosine kinase associated with growth and motility. Upon
stimulation of PDGFRb with PDGF-BB the receptor is dimerized
and auto-phosphorylated at several sites leading to recruitment of
GRB2 and SOS, which in turn activate the RAS-RAF-MEK-
ERK pathway. Upon sustained stimulation with PDGF-BB the
phosphorylated receptor becomes internalized while activated
ERK upregulates expression of downstream mRNA-targets e.g.
dual specificity phosphatase 6 (DUSP6), also called MKP-3 [9,10],
Figure 1. Method overview. (A) Upon stimulation with PDGF-BB the PDGFRb becomes autophosphorylated at various sites. This promotes
downstream signaling to ERK activation. Phosphorylated ERK translocates into the nucleus and enhances DUSP6 expression. Upon fixation of the cells
DUSP6 mRNA is reverse transcribed utilizing an LNA-modified primer. Subsequently the cDNA is made accessible through RNase H digestion. The
single standed cDNA stays attached to the mRNA-primer by the 59-end of the primer that contains the LNA bases, which is not recognized by RNase
H – to allow hybridization of padlock probes. (B) After ligation of the padlock probe to a circular DNA molecule, primary antibodies directed against
the PDGFRb and phosphorylated tyrosines, followed by addition of secondary PLA probes, are applied for detection of the phosphorylated PDGFRb.I f
the antibodies and probes are bound in close proximity two circularization oligonucleotides can hybridize to the PLA probes. (C) This molecule can
subsequently also be joined by ligation, giving rise to another circular DNA molecule. (D) Both DNA circles are then simultaneously amplified by RCA,
primed from either the cDNA or the oligonucleotide attached to the PLA probe. The resulting bundles of DNA (amplified ,1000 times) are still
attached to the place where the RCA was primed and can be detected by hybridization of fluorescence labeled oligonucleotides (different
fluorophores (green and pink stars) for the two types of circles), resulting in bright spots easily distinguishable from background.
doi:10.1371/journal.pone.0020148.g001
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thereby providing a negative feedback loop for its own expression
[10].
We used this model system to visualize the kinetics of ligand
stimulation at an initial stage – phosphorylation of the PDGFRb –
and a late stage – expression of the downstream target gene
DUSP6. Further, we applied drugs that target different nodes in
the pathway to test if the assay will be applicable to pinpoint the
molecular effect of a drug. Using the assay developed above,
treatment with drugs caused inhibition of either both phosphor-
ylation of the PDGFRb and DUSP6 expression or DUSP6
expression alone, depending on where on the pathway they act.
We demonstrated detection of cell-to-cell variations with single
molecule resolution in fixed cells. The method presented here
could be especially valuable when screening for new drugs, where
the effector molecules are still unknown or where the drugs should
only target a certain part of a signaling pathway.
Materials and Methods
Cell culture
TERT immortalized human fibroblast (BJhTert) [11] cells were
seeded on 8-well chamber slides (LabTek, Nunc), 20,000 cells per
well. The cells were allowed to attach overnight and subsequently
starved in Modified Eagle Medium (MEM, Gibco)+0.1% FCS
(heat-inactivated, Sigma) for 48 h. For stimulation PDGF-BB was
added to a final concentration of 100 ng ml
21 and the cells were
incubated at 37uC for the indicated time points. If the cells were
treated with drugs, the drugs Gleevec (Novartis) and 5-Iodotu-
bercidin (Sigma), dissolved in DMSO (Sigma) to a 10 mM stock
concentration, were applied at a final concentration of 10 mMi n
fresh MEM+0.1% FCS for 1 h at 37uC before PDGF-BB was
added at the indicated time points. The drug concentration was
held constant throughout the experiment.
For fixation the cells were put on ice and the medium was
immediately exchanged for ice-cold DEPC (Applichem Life-
science)-treated PBS (DEPC-PBS, 900 ml per well). After a 1 min
wash, the cells were fixed in 2% (w/v) paraformaldehyde (PFA,
Sigma Aldrich) in DEPC-PBS for 30 min at room temperature
(20–23uC). Prior to permeabilization in ice cold 70% ethanol for
30 min on ice, the cells were washed again in ice-cold DEPC-PBS.
Now the silicon mask of the chamber slides was removed, the slides
were dehydrated through a series of 70%, 85% and 99.5% ethanol
for ,1 min each, hydrophobic barrier pen was applied at the
borders of the slide wells and finally 8-chamber Secure Seals
(9 mm in diameter, 0.8 mm deep; Grace Bio-Labs) were attached
to the slides.
Preparation of secondary PLA probes
One mg donkey anti-rabbit IgG (711-005-152, Jackson
Immunoresearch) and 1 mg donkey anti-mouse IgG (715-005-
150, Jackson Immunoresearch) were concentrated over Amicon
ultra 0.5 ml, 10 kDa (UFC501008, Millipore) and dialyzed in
7 kD dialysis cup (Slide-A-Lyzer MINI dialysis units, #69562,
Pierce) against PBS over night at 4uC. Antibodies were activated in
SMCC (Pierce) added in 25-fold excess over antibody for 2 h at
room temperature. Primer oligonucleotide (59 thiol-AAA AAA
AAA ATA TGA CAG AAC TAG ACA CTC TT (Eurogentec))
and blocked oligonucleotide (59 thiol-AAA AAA AAA AGA CGC
TAA TAG TTA AGA CGC TTU UU (Biomers)) were degassed
at 95uC for 3 min and reduced by incubation with 25 mM DTT
for 1 h at 37uC. Both, antibodies and oligonucleotides were
purified using an Illustra NAP-5 column (#17-0853-01, GE
Healthcare), equilibrated and eluted with PBS+5 mM EDTA
pH 7.5. Afterwards anti-rabbit IgG was immediately mixed with
the primer oligonucleotide and anti-mouse IgG with the blocked
oligonucleotide. PLA probes were then dialyzed against PBS at
4uC overnight. Before purification by HPLC the conjugates were
concentrated to 25 ml by Amicon ultra 0.5 ml, 10 kDa columns
and 10 mM DTT was added to the conjugate to reduce unbound
oligonucleotide dimers. The conjugates were incubated for 10 min
at room temperature and subsequently injected into HPLC
(Hitachi D7000 series). Chromatography was done over a
Superdex 75 PC 3.2/30 column with a flow rate of 0.06 ml min
21
to separate conjugates from free oligonucleotides and samples
were collected at 16–20.5 min (conjugate peak).
Detection of phosphorylated PDGFRb with in situ PLA
The protocol is based on the protocol described previously in
Jarvius et al. 2007 [5]. All reactions were performed in Secure Seals
attached to the slides. Prior to each new step all liquids were
removed from the Secure Seal chambers and for incubations
exceeding 30 min the chambers were sealed with q-PCR film to
avoid evaporation. All washes were performed by flushing the
wells with ,500 ml of the appropriate washing buffer.
First the wells were rehydrated in 16 PBS-T (DEPC-
PBS+0.05% Tween20 (Sigma)) for 10 min at room temperature.
The cells were blocked in Protein-Block, serum free (Dako),
2.5 ng ml
21 sonicated salmon sperm DNA (Invitrogen) and
2.5 mM L-cysteine (Sigma) for 90 min at 37uC. After blocking
primary antibodies (63 ng ml
21 rabbit-anti-PDGFRb (#3169 Cell
Signaling) and 6 mgm l
21 mouse-anti-pY100 (#9411, Cell signal-
ing)) were applied in blocking solution over night at 4uC. Primary
antibodies were removed by flushing the chambers with ,500 ml
16 PBS-T. Secondary PLA probes (1.6 ng ml
21 donkey-anti-
rabbit-primer and 5 ng ml
21 donkey-anti-mouse-blocked, final
concentration, see above) were incubated separately in half the
final volume of blocking solution for 30 min at room temperature
before they were mixed and applied to the cells for 1 h at 37uC.
Subsequently the cells were washed in 10 mM Tris HCl pH 7.5,
0.1% Tween20 for 5 min at 37uC and once with 16 PBS-T.
Hybridization was done with 125 nM connector oligonucleotides
(59 phosphate-CTA TTA GCG TCC AGT GAA TGC GAG
TCC GTC TAA GAG AGT AGT ACA GCA GCC GTC AAG
AGT GTC TA (Eurogentec) and 59-phosphate-GTT CTG TCA
TAT TTA AGC GTC TTA A (Eurogentec)) in 16ligation buffer
(10 mM Tris acetate, pH 7.5, 10 mM magnesium acetate, 50 mM
potassium acetate), 0.25 mg ml
21 BSA (New England Biolabs),
0.05% Tween20, 250 mM NaCl for 30 min at 37uC. After a wash
in 16 PBS-T ligation was performed in 16 ligation buffer,
0.05 U ml
21 T4-DNA ligase (Fermentas), 1 mM ATP (Fermentas),
0.25 mg ml
21 BSA, 0.05% Tween20 and 250 mM NaCl for
30 min at 37uC. Subsequent to an additional washing step in 16
PBS-T, rolling circle amplification was done with 0.25 U ml
21
phi29 DNA polymerase (Fermentas) in 16 RCA buffer (50 mM
Tris-HCl, 10 mM MgCl2, 10 mM (NH4)2SO4, pH 7.5), 0.25 mM
dNTP (Fermentas), 0.2 mg ml
21 BSA, 5% glycerol (Sigma) 90 min
at 37uC. Before detection with 100 nM detection oligonucleotide
(59 Alexa 555-CAG TGA ATG CGA GTC CGT CT 39 (Trilink))
in 26 SSC, 0.25 mg ml
21 BSA, 75 ng ml
21 poly(A) (Sigma) and
0.05% Tween20, the cells were washed once in 16PBS-T. After
detection Secure Seals were removed and the slides were washed
twice in TBS for 10 min each. The cytoplasm of the cells was
thereafter counterstained with 2.5 mgm l
21 WGA 488 (Invitrogen)
diluted in 16DEPC-PBS for 30 min at room temperature. Final
washes were done 2610 min in TBS before the slides were spun
dry and mounted in Vectashield mounting medium (Vec-
tor)+100 ng ml
21 DAPI.
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probes and target-primed RCA
Primers and padlock probes were designed for the DUSP6 and
ACTB transcripts using GenBank accession numbers NM_001946
(DUSP6) and NM_001101.3 (ACTB). The primers used for in situ
synthesis were for DUSP6 59-CCG CTG GCT CTT AGT GTC
AAT GAA T-39 (Exiqon) and for ACTB transcripts 59-GTG
GAC GGG CGG CGG ATC GGC AAA G-39 (Exiqon). Bold
letters represent LNA-modified bases. The padlock probes and
detection oligonucleotides applied for detection of DUSP6 and
ACTB transcripts were 59 phosphate-GAG AGA GAT TCA TTG
TTC CTT TTA CGA CCT CAA TGC TGC TGC TGT ACT ACT
CTT CCT GGG CAG CTT CAT T (Integrated DNA
Technology) for DUSP6 and 59 phosphate-AGC CTC GCC
TTT GCC TTC CTT TTA CGA CCT CAA TGC ACA TGT TTG
GCT CCT CTT CGC CCC GCG AGC ACA G (Integrated DNA
Technology) for ACTB. Underscored letters denotes the target
complementary ends and italic letters represent the site and the
sequence of the respective detection oligonucleotides. The
detected DUSP6-transcripts were Cy3-labeled (MWG) for the
individual time series experiments and Cy5-labeled (Eurogentec)
in all other experiment. ACTB-transcripts were Cy5-labeled
(Integrated DNA Technology).
The in situ detection-procedure was performed in a similar way
as described by Larsson et al. [7]. Fixation, permeabilization and
dehydration of cells were however done as described above.
Subsequent to the application of the Secure Seals, the cells were
rehydrated in PBS-T. Reverse transcription was performed with
1 mM of the appropriate LNA-primer in 20 U ml
21 RevertAid H
minus M-MuLV reverse transcriptase (Fermentas), 0.5 mM
dNTPs, 0.2 mg ml
21 BSA, 1 U ml
21 Ribolock RNase inhibitor
(Fermentas) in M-MuLV reaction buffer. Slides were incubated for
3 h at 37uC and then washed twice in PBS-T. All subsequent
washes were performed in the same way. Postfixation was done in
2% (w/v) paraformaldehyde for 30 min at room temperature
before the slides were washed. To make the cDNA accessible for
padlock probe hybridization and to simultaneously ligate the
padlock probe to its target sequence, the cells were incubated with
0.1 mM padlock probe, 0.4 U ml
21 RNase H (Fermentas),
0.5 U ml
21 Ampligase (Epicentre), 1 U ml
21 Ribolock RNase
inhibitor in Ampligase buffer (20 mM Tris-HCl, pH 8.3,
75 mM KCl, 10 mM MgCl2, 0.5 mM NAD and 0.01% Triton
X-100), 20% formamide (Merck), first for 30 min at 37uC and
then for 45 min at 45uC. After an additional wash RCA was
performed with 1 U ml
21 phi29 DNA polymerase, 1 U ml
21
Ribolock RNase inhibitor in the supplied phi29 DNA polymerase
reaction buffer, 0.25 mM dNTPs, 0.2 mg ml
21 BSA and 5%
glycerol for 90 min at 37uC. RCPs were labeled with 0.25 mM
detection oligonucleotide in 26 SSC and 20% formamide for
15 min at 37uC. After detection the slides were washed twice in
PBS-T and Secure Seals were removed. The cytoplasm of the cells
was thereafter counterstained and the slides mounted as described
above.
Simultaneous in situ detection of individual
phosphorylated PDGFRb and DUSP6 or ACTB mRNA
The procedure for simultaneous detection of individual proteins
and transcripts in single cells was based on merging the two
protocols described above. The merged protocol started with in situ
reverse transcription, converting mRNA to DUSP6 and ACTB
cDNA. This was followed by post-fixation of the cells, digestion by
RNase H and hybridization/ligation of the specific padlock probes
to the target cDNA molecules. These steps were performed in the
same fashion as described above for solely transcript detection.
Thus, the padlock probes were locked onto their targets and the
target transcripts were secured. The combined protein/mRNA
protocol could subsequently proceed with the detection of
phosphorylated PDGFRb as described above except that
1Uml
21 Ribolock RNase inhibitor was added to the blocking,
antibody and PLA probe mixtures and DEPC-ddH2O was used
instead of ddH2O in hybridization and ligation. RCA was
performed as described for in situ PLA except that 2.5 U ml
21
phi29 DNA polymerase were used and both, padlock probes and
in situ PLA signals were amplified. For detection, the fluorescence
labeled oligonucleotides (see above), with a final concentration of
100 nM, were added to the detection mix described for in situ
PLA.
Image acquisition
Images were acquired using a Zeiss Axioplan 2 epifluorescence
microscope, the AxioCam MRm CCD sensor and a 206/0.8 Plan
Apochromat lens together with filters for DAPI, FITC, Cy3 and
Cy5. For each condition z-stacks were acquired at three positions
of the well and the positions were chosen using the FITC channel
(cytoplasm staining).
Image analysis and illustrations
Image J 1.44 d was used to make maximum intensity
projections (MIPs) of the image stack of each channel. In the
FITC channel, ImageJ was applied to enhance the contrast,
subtract background (rolling ball radius=200 pixel) and run a
median filter (radius 4 pixel). Background was also subtracted from
DAPI-images (rolling ball radius=50 pixel).
Subsequently, CellProfiler v.10415 was used to identify cell
nuclei (thresholding method: two-class thresholding ‘‘Otsu Per-
Object’’) in previously background subtracted DAPI images. The
nuclei were then combined with background corrected FITC
images to identify the cytoplasm of individual cells (method to
identify objects: ‘‘Watershed - Image’’, thresholding method: two-
class thresholding ‘‘Otsu Adaptive’’). Signals in Cy3 (PDGFRb)
and Cy5 (DUSP6 or ACTB) were enhanced (feature type:
‘‘speckles’’, feature size: 10), counted (diameter: 2–20 pixel,
thresholding method: ‘‘RobustBackground Global’’ (for Cy3),
diameter: 1–20 pixel, thresholding method ‘‘RobustBackground
Adaptive’’ (for Cy5), threshold correction factor: 0.8) and related
to the individual cells. Subsequently, if images did not contain
signals, the amount of signals had to be manually corrected, since
then the adaptive enhancement of Cy3 and Cy5 signals gave rise
to false positive signals. Graphs were done in R [12]. In Figure 1B
images were for better visualization treated in ImageJ as described
here: One slice of the DAPI z-stack was selected, background was
subtracted in ImageJ and thresholded for brightness and contrast.
Cy3 and Cy5 z-stacks were projected to MIPs, the background was
removed, brightness and contrast adjusted and a maximum filter
(size: 1 pixel) was applied.
Results
Kinetics of PDGFRb phosphorylation and DUSP6
expression
To determine the kinetics of PDGFRb phosphorylation and
DUSP6 expression upon stimulation with PDGF-BB, BJhTert cells
were starved for 48 h prior to treatment with 100 ng ml
21 PDGF-
BB. The cells were stimulated for different length of time (0 min–
240 min) and subsequently fixed. Thereafter the phosphorylation
of PDGFRb was investigated using in situ PLA with one antibody
directed against the receptor and one against phosphorylated
Signaling Activity in Single Cells
PLoS ONE | www.plosone.org 4 May 2011 | Volume 6 | Issue 5 | e20148tyrosine residues. In parallel, the expression on DUSP6 transcripts
was monitored by padlock probes on separate slides (Figure 2). As
expected, the phosphorylation of PDGFRb first increased
substantially during the initial time points, peaking at 5–10 min
after stimulation, before it gradually decreased again towards
background levels due to internalization of the receptor [9]. In
accordance with what has been reported before [10], DUSP6
transcript levels remained constant for the first 30 min of
stimulation, and then showed an increase until 3 h. Interestingly,
the distribution in numbers of detected molecules per cell in the
cell population is quite large, especially for PDGFRb phosphor-
ylation in response to stimulation. Regarding DUSP6 expression,
not all cells are responding to stimulation with PDGF-BB to the
same extent. It rather appears that, for the time investigated, some
cells burst with transcription while in others the signal is not
propagated to the induction of DUSP6 expression.
Combined detection of protein modification and mRNA
expression
Next, we tested the combined detection of protein modifications
and single transcripts (Figure 1). For this purpose phosphorylation
of PDGFRb and ACTB mRNA molecules – an abundantly
Figure 2. Individual detection of single phosphorylated PDGFRb and DUSP6 molecules in BJhTert cells. (A) Detection of individual
phosphorylated PDGFRb using in situ PLA in PDGF-BB-stimulated cells. Black circles represent the numbers of RCPs detected in individual cells (in
total ,90–130 cells per condition), the black bar represents the median of the population and grey boxes the 25% and 75% quartiles. The experiment
is a representative example of three replicate experiments. (B) Detection of individual DUSP6 mRNA molecules using padlock probes in BJhTert cells
stimulated with PDGF-BB for different length of time. Black circles represent the numbers of RCPs detected in individual cells (in total ,70–180 cells
per condition), the black bar represents the median of the population and grey boxes the 25% and 75% quartiles. The experiment is a representative
example of three replicate experiments.
doi:10.1371/journal.pone.0020148.g002
Figure 3. Individual and simultaneous detection of phosphorylated PDGFRb and ACTB mRNA molecules in PDGF-BB stimulated
BJhTert cells. Black circles represent the numbers of RCPs detected per cell (in total ,85–130 cells per condition), black bars represent the median
of the population and grey boxes the 25% and 75% quartiles. The experiment is a representative example of three replicate experiments. The result is
presented in separate figures for PDGFRb phosphorylation and ACTB expression, although recorded together.
doi:10.1371/journal.pone.0020148.g003
Signaling Activity in Single Cells
PLoS ONE | www.plosone.org 5 May 2011 | Volume 6 | Issue 5 | e20148expressed housekeeping gene to enable a more detailed analysis of
detection efficiency – were detected either individually or
simultaneously. The cells were fixed and permeabilized before
cDNA synthesis and padlock probe hybridization and ligation
were performed. After the ACTB cDNA had been targeted, the
cells were blocked and stained with in situ PLA reagents required to
detect phosphorylated PDGFRb. Both, reacted padlock probe and
in situ PLA probes were amplified in the same reaction by RCA
and detected by hybridization of fluorescence labeled detection
oligonucleotides. We investigated whether the combined detection
shows similar results as when the two detection reactions were run
separately, and whether there is a decrease in detection efficiency
upon combining the two. BJhTert cells were stimulated with
PDGF-BB for 0 min, 5 min or 180 min. The results of the
combined detection were consistent with the results of individual
staining and the levels of ACTB transcripts were unaffected by
stimulation with PDGF-BB, as expected. The combined protocol
leads to a decrease in detected signals for both in situ PLA and
padlock probes of about 50% compared to when performed in
separate reactions (Figure 3).
Drug induced inhibition of PDGFRb phosphorylation and
DUSP6 expression
Having developed a method that enabled measurement of both
protein activity and mRNA expression in single cells, we then
tested if the assay would be suitable to detect perturbation of the
PDGFRb-signaling pathway using drugs that affect the pathway at
different levels. In that way we were able to investigate if the assay
could help in zooming in on the action of a drug. As proof of
principle, we examined the effect of Gleevec (a tyrosine kinase
Figure 4. Simultaneous detection of individual phosphorylated PDGFRb and DUSP6 mRNA molecules in BJhTert cells. Cells were
stimulated for (Ai) 5 min or (Aii) 180 min with PDGF-BB. In situ PLA signals, derived from PDGFRb phosphorylation, are shown as red dots while DUSP6
molecules are shown as green dots. The nuclei are shown in grey. Inserts represent magnified views over random cells. Scalebars represent 20 mm. (B)
Simultaneous detection of individual phosphorylated PDGFRb and DUSP6 mRNA molecules cells treated with Gleevec or 5-Iodotubercidin at different
time points after PDGF-BB stimulation. (Bi) Schematic illustration of the different drug target sites in PDGFRb pathway and the consequences for
signaling and expected RCPs. (Bii) Simultaneous detection of individual phosphorylated PDGFRb and DUSP6 mRNA molecules in BJhTert cells treated
with Gleevec or 5-Iodotubercidin, at different time points after PDGF-BB stimulation. Black circles represent the numbers of RCPs detected per cell (in
total ,100–140 cells per condition), the red bar represents the median of the population and grey boxes the 25% and 75% quartiles. The experiment
is a representative example of three replicate experiments. The result is presented in separate figures for PDGFRb phosphorylation and DUSP6
expression, although recorded together.
doi:10.1371/journal.pone.0020148.g004
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din (an inhibitor of ERK2 activation [14], located downstream of
PDGFRb but upstream of the induction of DUSP6 transcription)
on phosphorylation of PDGFRb and DUSP6 expression. As
expected, treatment with Gleevec eliminated the increase in
signals for both molecules, since it inhibits the activation of the
PDGFRb and thus all downstream events. 5-Iodotubercidin, on
the other hand, did only eliminate the upregulation of DUSP6 but
not phosphorylation of the PDGFRb, since it affected the signaling
downstream of the receptor but upstream of DUSP6 (Figure 4).
Discussion
We herein successfully combined in situ PLA and padlock probes
for detection of individual phosphorylated PDGFRb and DUSP6
transcripts in a single cell assay. First, the kinetics of each molecule
was investigated in separate reactions and both molecules were
detected as expected. The level of DUSP6 expression previously
reported, ,1% compared to ACTB [15], are in agreement with
the levels determined herein, confirming the ,30% efficiency of
mRNA detection using padlock probes in situ [7]. For protein
detection the efficiency of in situ PLA is less, a few percent,
depending on antibody affinity and quality of the PLA probes.
However, detection of phosphorylated PDGFRb using in situ PLA
correlates with levels determined in a population based assay using
immunoblot [5]. Combining in situ PLA with padlock probes
detecting mRNA in situ did not affect detection of phosphorylated
PDGFRb upon stimulation with PDGF-BB. ACTB mRNA levels
were largely unaffected by stimulation with PDGF-BB (Figure 3).
However, the combined detection scheme decreased the signals for
both targets to ,50% compared to individual detection, most
likely since the protocol is longer and involves more washing steps
than individual detection.
We then demonstrated in a proof-of-principle experiment how
this combined detection could be applied for screening of new
drugs or signal transduction studies, treating BJhTert cells with
either Gleevec or 5-Iodotubercidin. Subsequently PDGF-BB was
added at different time points and phosphorylation of PDGFRb,
as well as expression of DUSP6 transcripts, was measured in the
same cells. As expected, treatment with Gleevec inhibited
PDGFRb phosphorylation, and consequently also impaired the
induction of DUSP6 expression. 5-Iodotubercidin inhibited ERK2
activation and therefore did not affect PDGFRb phosphorylation
but did inhibit DUSP6 expression, which is dependent on ERK2
activation.
Both in situ PLA and padlock probes allow detection of
individual target molecules at endogenous levels in individual
cells. Even after synchronization of the cells by serum starvation
for 48 h prior to stimulation, there was still a broad distribution in
how many target molecules per cell that were detected. The
difference in amount of RCPs per cell can partially be explained
by differences in cell size but might also reflect differences in
response time or intensity. Especially when looking at DUSP6
transcript expression, some cells seem to burst with expression,
while others remain at background levels, as previously described
for other mRNA molecules [3]. As the measurements are
performed in fixed samples, transient interactions/activations
and bursts of expression between the different time points will
not be recorded. Nevertheless, the assay provides information on
frequency of expressing cells and levels of expression at the time of
analyses. This cell-to-cell heterogeneity would have gone unde-
tected if instead an averaging method would have been used. The
possibility to simultaneously measure multiple parameters provides
an advantage when more complex cell populations are studied,
e.g. tissue sections, as they consists of a mixture of cell types, at
various differentiation stages, responding to various external
stimuli. Moreover, a simultaneous detection is advantageous in
cases with rare or/and small sample size.
The combined method for detection of individual protein
modifications and individual mRNA molecules in single cells in situ
presented here may be a valuable tool to enable broader studies of
signaling pathways. A further advantage: as the method is based
upon imaging, differences between individual cells with respect to
target molecule location, amount and modifications can be
investigated together with morphological characteristics of the
cells. Importantly, data about protein modification and mRNA
expression can be related to the same cell. This might be of
particular interest when new drugs are tested, especially such that
should act very specifically and locally in a signaling pathway. In
this paper we show detection of one specific post-translational
modification and one specific transcript, but further developments
of each individual method could also be applied to this combined
technique. The main advantage with the strategy described herein
lies in simultaneous targeting of multiple nodes in a signaling
cascade to determine how a drug effects the propagation of the
signals. This will allow studies in heterogeneous populations and
provides a tool to determine if a drug can rewire a signaling circuit
i.e., changing the balance in nodes where there are alternative
interaction partners. In that way more branch points and levels of
regulation can be revealed simultaneously, providing additional
information on the activity status in individual cells that will
reduce cost and increase throughput in high content analyses.
Acknowledgments
We would like to thank Carla Annink for her help with the conjugations
and Rolf Larsson for kindly providing Gleevec.
Author Contributions
Conceived and designed the experiments: IW IG MN OS. Performed the
experiments: IW IG. Analyzed the data: IW IG. Wrote the paper: IW IG
MN OS.
References
1. Levsky JM, Singer RH (2003) Gene expression and the myth of the average cell.
Trends Cell Biol 13: 4–6.
2. Sigal A, Milo R, Cohen A, Geva-Zatorsky N, Klein Y, et al. (2006) Variability
and memory of protein levels in human cells. Nature 444: 643–646.
3. Raj A, Peskin CS, Tranchina D, Vargas DY, Tyagi S (2006) Stochastic mRNA
synthesis in mammalian cells. PLoS Biol 4: e309.
4. Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius KJ, et al.
(2006) Direct observation of individual endogenous protein complexes in situ by
proximity ligation. Nat Methods 3: 995–1000.
5. Jarvius M, Paulsson J, Weibrecht I, Leuchowius KJ, Andersson AC, et al. (2007)
In situ detection of phosphorylated platelet-derived growth factor receptor beta
using a generalized proximity ligation method. Mol Cell Proteomics 6:
1500–1509.
6. Larsson C, Koch J, Nygren A, Janssen G, Raap AK, et al. (2004) In situ
genotyping individual DNA molecules by target-primed rolling-circle amplifi-
cation of padlock probes. Nat Methods 1: 227–232.
7. Larsson C, Grundberg I, Soderberg O, Nilsson M (2010) In situ detection and
genotyping of individual mRNA molecules. Nat Methods 7: 395–397.
8. Nilsson M, Krejci K, Koch J, Kwiatkowski M, Gustavsson P, et al. (1997)
Padlock probes reveal single-nucleotide differences, parent of origin and in situ
distribution of centromeric sequences in human chromosomes 13 and 21. Nat
Genet 16: 252–255.
9. Heldin CH, Ostman A, Ronnstrand L (1998) Signal transduction via platelet-
derived growth factor receptors. Biochim Biophys Acta 1378: F79–113.
10. Jurek A, Amagasaki K, Gembarska A, Heldin CH, Lennartsson J (2009)
Negative and positive regulation of MAPK phosphatase 3 controls platelet-
Signaling Activity in Single Cells
PLoS ONE | www.plosone.org 7 May 2011 | Volume 6 | Issue 5 | e20148derived growth factor-induced Erk activation. J Biol Chem 284: 4626–
4634.
11. Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, et al. (1999) Telomerase
expression in human somatic cells does not induce changes associated with a
transformed phenotype. Nat Genet 21: 111–114.
12. Team RDC (2010) R: A Language and Environment for Statistical Computing.
http://www.R-project.org.
13. Buchdunger E, Zimmermann J, Mett H, Meyer T, Muller M, et al. (1996)
Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-
phenylaminopyrimidine derivative. Cancer Res 56: 100–104.
14. Fox T, Coll JT, Xie X, Ford PJ, Germann UA, et al. (1998) A single amino acid
substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38
MAP kinase. Protein Sci 7: 2249–2255.
15. Ekerot M, Stavridis MP, Delavaine L, Mitchell MP, Staples C, et al. (2008)
Negative-feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by
ERK1/2 and mediated by Ets factor binding to a conserved site within the
DUSP6/MKP-3 gene promoter. Biochem J 412: 287–298.
Signaling Activity in Single Cells
PLoS ONE | www.plosone.org 8 May 2011 | Volume 6 | Issue 5 | e20148